Complement in the Pathophysiology and Diagnosis of Human Diseases

References

• Müller-Eberhard H. J. Complement. Annu. Rev. Biochem. 1975; 44: 697
   PubMed Web of Science ®Google Scholar
• Reid K. B. M., Porter R. R. The proteolytic activation systems of complement. Annu. Rev. Biochem. 1981; 50: 433
   PubMed Web of Science ®Google Scholar
• Ziccardi R. J. The first component of human complement (C1): activation and control. Springer Semin. Immunopathol. 1983; 6: 213
   Google Scholar
• Cooper N. R. The classical complement pathway: activation and regulation of the first complement component. Adv. Immunol. 1985; 37: 151
   PubMed Web of Science ®Google Scholar
• Porter R. R. The complement components of the major histocompatibility locus. Crit. Rev. Biochem. 1984; 16: 1
   Web of Science ®Google Scholar
• Hugli T. E. Structure and function of the anaphylatoxins. Springer Semin. Immunopathol. 1984; 7: 193
   PubMed Web of Science ®Google Scholar
• Tack B. F. The β-cys-γ-glu thiolester bond in human C3, C4, and αz,-macroglobulin. Springer Semin. Immunopathol. 1983; 6: 259
   PubMed Web of Science ®Google Scholar
• Law S. K., Levine R. P. Interaction between the third complement protein and cell surface macromolecules. Proc. Natl. Acad. Sci. U.S.A. 1977; 74: 2701
   PubMed Web of Science ®Google Scholar
• Müller-Eberhard H. J., Dalmasso A. P., Calcott M. A. The reaction mechanism of βlc-globulin (C'3) in immune hemolysis. J. Exp. Med. 1966; 123: 33
   PubMed Web of Science ®Google Scholar
• Gigli I., Fujita T., Nussenzweig V. Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivator. Proc. Natl. Acad. Sci. U.S.A. 1979; 76: 6596
   PubMed Web of Science ®Google Scholar
• Lachmann P. J., Pangburn M. K., Oldroyd R. G. Breakdown of C3 after complement activation. Identification of a new fragment, C3g, using monoclonal antibodies. J. Exp. Med. 1982; 156: 205
   PubMed Web of Science ®Google Scholar
• Fearon D. T., Wong W. W. Complement ligand-receptor interactions that mediate biological responses. Annu. Rev. Immunol. 1983; 1: 243
   PubMed Web of Science ®Google Scholar
• Gewurz H., Shin H. S., Mergenhagen S. E. Interactions of the complement system with endotoxic lipopolysaccharide: consumption of each of the six terminal complement components. J. Exp. Med. 1968; 128: 1049
   PubMed Web of Science ®Google Scholar
• Müller-Eberhard H. J., Schreiber R. D. Molecular biology and chemistry of the alternative pathway of complement. Adv. Immunol. 1980; 29: 1
   PubMedGoogle Scholar
• Ratnoff W. D., Fearon D. T., Austen K. F. The role of antibody in the activation of the alternative complement pathway. Springer Semin. Immunopathol. 1983; 6: 361
   PubMedGoogle Scholar
• Pangburn M. K., Müller-Eberhard H. J. The alternative pathway of complement. Springer Semin. Immunopathol. 1984; 7: 163
   PubMed Web of Science ®Google Scholar
• Nelson B., Ruddy S. Enhancing role of IgG in lysis of rabbit erythrocytes by the alternative pathway of human complement. J. Immunol. 1979; 122: 1994
   Google Scholar
• Dalmasso A. P., Müller-Eberhard H. J. Hemolytic activity of lipoprotein-depleted serum and the effect of certain anions on complement. J. Immunol. 1966; 97: 680
   Google Scholar
• Kazatchkine M. D., Fearon D. T., Austen K. F. Human alternative complement pathway: membrane-associated sialic acid regulates the competition between B and β1H for cell-bound C3b. J. Immunol. 1979; 122: 75
   PubMed Web of Science ®Google Scholar
• Hoffmann E. M. Inhibition of complement by a substance isolated from human erythrocytes. II. Studies on the site and mechanism of action. Immunochemistry 1969; 6: 405
   Google Scholar
• Nicholson-Weller A., Burge J., Fearon D. T., Weller P. F., Austen K. F. Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system. J. Immunol. 1982; 129: 184
   PubMed Web of Science ®Google Scholar
• Davis A. E., III, Ziegler J. B., Gelfand E. W., Rosen F. S., Alper C. A. Heterogeneity of nephritic factor and its identification as an immunoglobulin. Proc. Natl. Acad. Sci. U.S.A. 1977; 74: 3980
   Google Scholar
• Daha M. R., Austen K. F., Fearon D. T. The incorporation of C3 nephritic factor (C3NeF) into a stabilized C3 convertase, C3bBb(C3NeF), and its release after decay of convertase function. J. Immunol 1977; 119: 812
   Google Scholar
• Mayer M. M., Michaels D. W., Ramm L. E., Whitlow M. B., Willoughby J. B., Shin M. L. Membrane damage by complement. Crit. Rev. Immunol. 1981; 2: 133
   Google Scholar
• Müller-Eberhard H. J. The membrane attack complex. Springer Semin. Immunopathol. 1984; 7: 93
   PubMedGoogle Scholar
• Podack E. R., Tschopp J. Membrane attack by complement. Mol. Immunol. 1984; 21: 589
   PubMed Web of Science ®Google Scholar
• Kolb W. P., Haxby J. A., Arroyave C. M., Müller-Eberhard H. J. The membrane attack mechanism of complement. Reversible interactions among the five native components in free solution. J. Exp. Med. 1973; 138: 428
   Google Scholar
• Podack E. R., Tschopp J., Müller-Eberhard H. J. Molecular organization of C9 within the membrane attack complex of complement. Induction of circular C9 polymerization by the C5b-8 assembly. J. Exp. Med. 1982; 156: 268
   Google Scholar
• Borsos T., Dourmashkin R. R., Humphrey J. H. Lesions in erythrocyte membranes caused by immune haemolysis. Nature (London) 1964; 202: 251
   PubMed Web of Science ®Google Scholar
• Giavedoni E. B., Dalmasso A. P. The induction by complement of a change in KSCN-dissoci-able red cell membrane lipids. J. Immunol. 1976; 116: 1163
   Google Scholar
• Bhakdi S., Bjerrum O. J., Bhakdi-Lehnen B., Tranum-Jensen J. Complement lysis: evidence for an amphiphilic nature of the terminial membrane C5b-9 complex of human complement. J. Immunol. 1978; 121: 2526
   Google Scholar
• Esser A. F. Interactions between complement proteins and biological and model membranes. Biological Membranes, D. Chapman. Academic Press, New York 1982; 277
   Google Scholar
• Ramm L. E., Whitlow M. B., Mayer M. M. Size of the transmembrane channels produced by complement proteins C5b-8. J. Immunol. 1982; 129: 1143
   Google Scholar
• Dalmasso A. P., Benson B. A. Lesions of different functional size produced by human and guinea pig complement in sheep red cell membranes. J. Immunology 1981; 127: 2214
   Google Scholar
• Dalmasso A. P., Benson B. A., Falk R. J. Complement channels in membranes: inhibition with a monoclonal antibody to a neoantigen of polymerized C9. Biochem. Biophys. Res. Commun. 1984; 125: 1013
   Google Scholar
• Packman C. H., Rosenfeld S. I., Leddy J. P. High-density lipoprotein and its apolipoproteins inhibit cytolytic activity of complement. Studies on the nature of inhibitory moiety. Biochem. Biophys. Acta 1985; 812: 107
   Google Scholar
• Arnaout M. A., Colten H. R. Complement C3 receptors: structure and function. Mol. Immunol. 1984; 21: 1191
   Google Scholar
• Schreiber R. D. The chemistry and biology of complement receptors. Springer Semin. Immunopathol 1984; 7: 221
   Google Scholar
• Ross G. D., Atkinson J. P. Complement receptor structure and function. Immunol Today 1985; 6: 115
   Google Scholar
• Ross G. D., Medof M. E. Membrane complement receptors specific for bound fragments of C3. Adv. Immunol 1985; 37: 217
   PubMed Web of Science ®Google Scholar
• Tenner A. J., Cooper N. R. Identification of types of cells in human peripheral blood that bind Clq. J. Immunol 1981; 126: 1174
   Google Scholar
• Nelson R. A., Jr. The immune-adherence phenomenon. An immunologically specific reaction between microorganisms and erythrocytes leading to enhanced phagocytosis. Science 1953; 118: 733
   PubMed Web of Science ®Google Scholar
• Gelfand M. C, Frank M. M., Green I. A receptor for the third component of complement in the human renal glomerulus. J. Exp. Med. 1975; 142: 1029
   Google Scholar
• Kazatchkine M. D., Fearon D. T., Appay M. D., Mandet C, Bariety J. Immunohistochemical study of the human glomerular C3b receptor in normal kidney and in seventy-five cases of renal diseases. Loss of C3b receptor antigen in focal hyalinosis and in proliferative nephritis of systemic lupus erythematosus. J. Clin. Invest. 1982; 69: 900
   PubMed Web of Science ®Google Scholar
• Wilson J. G., Fearon D. T. Altered expression of complement receptors as a pathogenic factor in systemic lupus erythematosus. Arthritis Rheum. 1984; 27: 1321
   PubMedGoogle Scholar
• Weis J. J., Tedder T. F., Fearon D. T. Identification of a 145,000 M, membrane protein as the C3d receptor (CR2) of human B lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 1984; 81: 881
   PubMed Web of Science ®Google Scholar
• Wright S. D., Rao P. E., Van Voorhis W. C, Craigmyle L. S., Iida K., Talle M. A., Westberg E. F., Goldstein G., Silverstein S. C. Identification of the C3bi receptor of human monocytes and macrophages by using monoclonal antibodies. Proc. Natl. Acad. Sci. U.S.A. 1983; 80: 5699
   PubMed Web of Science ®Google Scholar
• Ghebrehiwet B., Müller-Eberhard H. J. C3e: an acidic fragment of human C3 with leukocyto-sis-inducing activity. J. Immunol. 1979; 123: 616
   PubMed Web of Science ®Google Scholar
• Lambris J. D., Ross G. D. Characterization of the lymphocyte membrane receptor for factor H (β1H-globulin) with an antibody to anti-factor H idiotype. J. Exp. Med. 1982; 155: 1400
   Google Scholar
• Takahashi M., Czop J., Ferreira A., Nussenzweig V. Mechanism of solubilization of immune aggregates by complement. Implications for immunopathology. Transplant Rev. 1976; 32: 121
   PubMed Web of Science ®Google Scholar
• Takahashi M., Takahashi S., Hirose S. Solubilization of antigen-antibody complexes: a new function of complement as a regulator of immune reactions. Prog. Allergy 1980; 27: 134
   PubMedGoogle Scholar
• Weigle W. O., Goodman M. G., Morgan E. L., Hugli T. E. Regulation of immune response by components of the complement cascade and their activated fragments. Springer Semin. Immunopathol. 1983; 6: 173
   Google Scholar
• Hugli T. E., Müller-Eberhard H. J. Anaphylatoxins: C3a and C5a. Adv. Immunol 1978; 26: 1
   PubMedGoogle Scholar
• Hugli T. E. The structural basis for anaphylatoxin and chemotactic functions of C3a, C4a, and C5a. Crit. Rev. Immunol. 1981; 1: 321
   Google Scholar
• Ward P. A. Chemotaxis of mononuclear cells. J. Exp. Med. 1968; 128: 1201
   PubMed Web of Science ®Google Scholar
• Fernandez H. N., Henson P. M., Otani A., Hugli T. E. Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under simulated in vivo conditions. J. Immunol. 1978; 120: 109
   PubMed Web of Science ®Google Scholar
• Craddock P. R., Fehr J., Dalmasso A. P., Brigham K. L., Jacob H. S. Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes. J. Clin. Invest. 1977; 59: 879
   PubMed Web of Science ®Google Scholar
• Craddock P. R., Hammerschmidt D., White J. G., Dalmasso A. P., Jacob H. S. Complement (C5a)-induced granulocyte aggregation in vitro. A possible mechanism of complement-mediated leukostasis and leukopenia. J. Clin. Invest. 1977; 60: 260
   PubMed Web of Science ®Google Scholar
• Stimler N. P., Bach M. K., Bloor C. M., Hugli T. E. Release of leukotrienes from guinea pig lung stimulated by C5ades Arg anaphylatoxin. J. Immunol. 1982; 128: 2247
   Google Scholar
• Hartung H. P., Bitter-Suermann D., Hadding U. Induction of thromboxane release from macrophages by anaphylatoxic peptide C3a of complement and synthetic hexapeptide C3a 72–77. J. Immunol. 1983; 130: 1345
   Google Scholar
• Bokisch V. A., Müller-Eberhard H. J. Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidase. J. Clin. Invest. 1970; 49: 2427
   PubMed Web of Science ®Google Scholar
• Rother K. Leukocyte mobilizing factor: a new biological activity derived from the third component of complement. Eur. J. Immunol. 1972; 2: 550
   Google Scholar
• Gigli I., Nelson R. A. Complement dependent immune phagocytosis. Requirements for C'1, C'4, C'2, C'3. Exp. Cell Res. 1968; 51: 45
   PubMed Web of Science ®Google Scholar
• Ehlenberger A. G., Nussenzweig V. The role of membrane receptors for C3b and C3d in phagocytosis. J. Exp. Med. 1977; 145: 357
   PubMed Web of Science ®Google Scholar
• Schreiber R. D., Pangburn M. K., Bjornson A. B., Brothers M. A., Müller-Eberhard H. J. The role of C3 fragments in endocytosis and extracellular cytotoxic reactions by polymorphonuclear leukocytes. Clin. Immunol. Immunopathol. 1982; 23: 335
   PubMedGoogle Scholar
• Sundsmo J. S., Götze O. Human monocyte spreading induced by factor Bb of the alternative pathway of complement activation. A possible role for C5 in monocyte spreading. J. Exp. Med. 1981; 154: 763
   Google Scholar
• Wahlin B., Perlmann H., Perlmann P., Schreiber R. D., Müller-Eberhard H. J. C3 receptors on human lymphocyte subsets and recruitment of ADCC effector cells by C3 fragments. J. Immunol. 1983; 130: 2831
   Google Scholar
• Goldstein I. M. Complement in infectious diseases. Current Concepts. Scope Publications, Upjohn Company, Kalamazoo, Mich. 1980
   Google Scholar
• Fine D. P. Complement and Infectious Diseases. CRC Press, Boca Raton, Fla. 1981
   Google Scholar
• Joiner K. A., Brown E. J., Frank M. M. Complement and bacteria: chemistry and biology in host defense. Annu. Rev. Immunol. 1984; 2: 461
   PubMed Web of Science ®Google Scholar
• Cooper N. R., Nemerow G. R. Complement, viruses, and virus-infected cells. Springer Semin. Immunopathol. 1983; 6: 327
   PubMed Web of Science ®Google Scholar
• Hirsch R. L. The complement system: its importance in the host response to viral infection. Microbiol. Rev. 1982; 46: 71
   Google Scholar
• Lachmann P. J. Antibody and complement in viral infections. Br. Med. Bull. 1985; 41: 3
   Google Scholar
• Volanakis J. E. Complement activation by C-reactive protein complexes. Ann. N.Y. Acad. Sci. 1982; 389: 235
   Google Scholar
• Mold C, Du Clos T. W., Nakayama S., Edwards K. M., Gewurz H. C-reactive protein reactivity with complement and effects on phagocytosis. Ann. N. Y. Acad. Sci. 1982; 389: 251
   Google Scholar
• Takahashi M., Takahashi S., Brade V., Nussenzweig V. Requirements for the solubilization of immune aggregates by complement. The role of the classical pathway. J. Clin. Invest. 1978; 62: 349
   Google Scholar
• Naama J. K., Hamilton A. O., Yeung-Laiwah A. C, Whaley K. Prevention of immune precipitation by purified classical pathway complement components. Clin. Exp. Immunol. 1984; 58: 486
   Google Scholar
• Fujita T., Takata Y., Tamura N. Solubilization of immune precipitates by six isolated alternative pathway proteins. J. Exp. Med. 1981; 154: 1743
   Google Scholar
• Schifferli J. A., Bartolotti S. R., Peters D. K. Inhibition of immune precipitation by complement. Clin. Exp. Immunol. 1980; 42: 387
   PubMedGoogle Scholar
• Cornacoff J. B., Hebert L. A., Smead W. L., VanAman M. E., Birmingham D. J., Waxman F. J. Primate erythrocyte-immune complex-clearing mechanism. J. Clin. Invest. 1983; 71: 236
   PubMed Web of Science ®Google Scholar
• Waxman F. J., Hebert L. A., Cornacoff J. B., VanAman M. E., Smead W. L., Kraut E. H., Birmingham D. J., Taguiam J. M. Complement depletion accelerates the clearance of immune complexes from the circulation of primates. J. Clin. Invest. 1984; 74: 1329
   Google Scholar
• Dukor P., Hartmann K. U. Bound C3 as the second signal for B-cell activation. Cell. Immunol. 1973; 7: 349
   Google Scholar
• Pepys M. B., Butterworth A. E. Inhibition by C3 fragments of C3-dependent rosette formation and antigen-induced lymphocyte transformation. Clin. Exp. Immunol. 1974; 18: 273
   Google Scholar
• Needleman B. W., Weiler J. M., Feldbush T. L. The third component of complement inhibits human lymphocyte blastogenesis. J. Immunol. 1981; 126: 1586
   Google Scholar
• Goodman M. G., Chenoweth D. E., Weigle W. O. Induction of interleukin 1 secretion and enhancement of humoral immunity by binding of human C5a to macrophage surface C5a receptors. J. Exp. Med. 1982; 156: 912
   PubMed Web of Science ®Google Scholar
• Rapp H. J., Borsos T. Molecular Basis of Complement Action. Appleton-Century-Crofts, New York 1970
   Google Scholar
• Williams C. A., Chase M. W. Complement. Methods in Immunology and Immunochemistry. Academic Press, New York 1977; Vol. 4: 127
   Google Scholar
• Gewurz H., Suyehira L. A. Complement. Manual of Clinical Immunology, N. R. Rose, H. Friedman. American Society for Microbiology, Washington, D.C. 1980; 163
   Google Scholar
• Cooper N. R., Nemerow G. R., Mayes J. T. Methods to detect and quantitate complement activation. Springer Semin. Immunopathol. 1983; 6: 195
   PubMed Web of Science ®Google Scholar
• Gaither T. A., Frank M. M. Complement. Clinical Diagnosis and Management by Laboratory Methods, J. B. Henry. W.B. Saunders, Philadelphia 1984; 879
   Google Scholar
• Newell S., Gorman J. C, Bell E., Atkinson J. P. Hemolytic and antigenic measurements of complement. A comparison of serum and plasma samples in normal individuals and patients. J. Lab. Clin. Med. 1982; 100: 437
   Google Scholar
• Bouvenot G., Bartolin R., Arnaud C, de Régis M., Rakoto J. P., Bruguerolle B. Variations circadiennes sériques des protéines totales, des IgM et de la fraction C3 due complément chez quar-ante hommes adultes en bonne santé apparante. Pathol. Biol. 1984; 32: 173
   Google Scholar
• Roach B., Kim Y., Jerome E., Michael A. F. Influence of age and sex on serum complement components in children. Am. J. Dis. Child. 1981; 135: 918
   Google Scholar
• de Bracco M. M. E., Dalmasso A. P. Effect of the cationic environment on immune haemolysis of high potassium and low potassium sheep erythrocytes. Immunology 1969; 17: 559
   Google Scholar
• Nilsson U. R., Nilsson B. Simplified assays of hemolytic activity of the classical and alternative complement pathways. J. Immunol. Methods 1984; 72: 49
   PubMed Web of Science ®Google Scholar
• Gewurz A. T., Lint T. F., Imherr S. M., Garber S. S., Gewurz H. Detection and analysis of inborn and acquired complement abnormalities. Clin. Immunol. Immunopathol. 1982; 23: 297
   PubMedGoogle Scholar
• Morgan B. P., Campbell A. K., Compston D. A. S. Terminal component of complement (C9) in cerebrospinal fluid of patients with multiple sclerosis. Lancet 1984; 2: 251
   Google Scholar
• Cooper N. R., Ziccardi R. J. Reconstitution of C1 in native, proenzyme form and its use in a quantitative CI activation test. J. Immunol. 1977; 119: 1664
   PubMed Web of Science ®Google Scholar
• Arroyave C. M., Tan E. M. Detection of complement activation by counterimmunoelectrophoresis (CIE). J. Immunol. Methods 1976; 13: 101
   PubMed Web of Science ®Google Scholar
• Laurell C. B., Lundh B. Electrophoretic studies of the conversion products of serum β1c-globulin. Immunology 1967; 12: 313
   PubMedGoogle Scholar
• Wagner J. L, Hugli T. E. Radioimmunoassay for anaphylatoxins: a sensitive method for determining complement activation products in biological fluids. Anai. Biochem. 1984; 136: 75
   PubMed Web of Science ®Google Scholar
• Brandslund I., Siersted H. C, Svehag S. E., Teisner B. Double-decker rocket Immunoelectrophoresis for direct quantitation of complement C3 split products with C3d specificities in plasma. J. Immunol. Methods 1981; 44: 63
   PubMed Web of Science ®Google Scholar
• Milgrom H., Curd J. G., Kaplan R. A., Müller-Eberhard H. J., Vaughan J. H. Activation of the fourth component of complement (C4): assessment by rocket immunoelectrophoresis in correlation with the metabolism of C4. J. Immunol. 1980; 124: 2780
   PubMed Web of Science ®Google Scholar
• Ziccardi R. J., Cooper N. R. Demonstration and quantitation of activation of the first component of complement in human serum. J. Exp. Med. 1978; 147: 385
   Google Scholar
• Ziccardi R. J., Cooper N. R. Development of an immunochemical test to assess C inactivator function in human serum and its use for the diagnosis of hereditary angioedema. Clin. Immunol. Immunopathol. 1980; 15: 465
   PubMedGoogle Scholar
• Hack C. E., Hannema A. J., Eerenberg-Belmer A. J. M., Out T. A., Aalberse R. C. A C-inhibitor-complex assay (INCA): a method to detect C1 activation in vitro and in vivo. J. Immunol. 1981; 127: 1450
   Google Scholar
• Mayes J. T., Schreiber R. D., Cooper N. R. Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum. J. Clin. Invest. 1984; 73: 160
   PubMedGoogle Scholar
• Falk R. J., Dalmasso A. P., Kim Y., Lam S., Michael A. Radioimmunoassay of the attack complex of complement in serum from patients with systemic lupus erythematosus. N. Engl. J. Med. 1985; 312: 1594
   Google Scholar
• Garratty G. The significance of complement in immunohematology. Crit. Rev. Clin. Lab. Sci. 1984; 20: 25
   Google Scholar
• Kerr R. O., Dalmasso A. P., Kaplan M. E. Erythrocyte-bound C5 and C6 in autoimmune hemolytic anemia. J. Immunol. 1971; 107: 1209
   Google Scholar
• Lachmann P. J., Voak D., Oldroyd R. G., Downie D. M., Bevan P. C. Use of monoclonal anti-C3 antibodies to characterise the fragments of C3 that are found on erythrocytes. Vox Sang. 1983; 45: 367
   Google Scholar
• Sirois M., Chartier C, Brun G., Hamel Y., Petitclerc C, Delage J. M. An enzyme-linked immunosorbent assay for the detection of complement components on red blood cells. Am. J. Clin. Pathol. 1984; 82: 67
   Google Scholar
• Cines D. B., Wilson S. B., Tomaski A., Schreiber A. D. Platelet antibodies of the IgM class in immune thrombocytopenic purpura. J. Clin. Invest. 1985; 15: 1183
   Google Scholar
• Alper C. A., Rosen F. S. Studies of the in vivo behavior of human C'3 in normal subjects and patients. J. Clin. Invest. 1967; 46: 2021
   PubMed Web of Science ®Google Scholar
• Bokisch V. A., Top F. H., Russell P. K., Dixon F. J., Müller-Eberhard H. J. The potential pathogenic role of complement in dengue hemorrhagic shock syndrome. N. Engl. J. Med. 1973; 289: 996
   PubMed Web of Science ®Google Scholar
• Charlesworth J. A., Williams D. G., Sherington E., Lachmann P. J., Peters D. K. Metabolic studies of the third component of complement and the glycine-rich beta glycoprotein in patients with hypocomplementemia. J. Clin. Invest. 1974; 53: 1578
   PubMed Web of Science ®Google Scholar
• Ruddy S., Carpenter C. B., Chin K. W., Knostman J. N., Soter N. A., Götze O., Müller-Eberhard H. J., Austen K. F. Human complement metabolism: an analysis of 144 studies. Medicine 1975; 54: 165
   Web of Science ®Google Scholar
• Alper C. A. Inherited structural polymorphism in human C2: evidence for genetic linkage between C2 and Bf. J. Exp. Med. 1976; 144: 1111
   PubMed Web of Science ®Google Scholar
• Alper C. A., Boenisch T., Watson L. Genetic polymorphism in human glycine-rich beta-glycoprotein. J. Exp. Med. 1972; 135: 68
   PubMed Web of Science ®Google Scholar
• Awdeh Z. L., Alper C. A. Inherited structural polymorphism of the fourth component of human complement. Proc. Natl. Acad. Sci. U.S.A. 1980; 77: 3576
   PubMed Web of Science ®Google Scholar
• O'Neill G. J. C4 polymorphism: use of a monoclonal antibody to distinguish C4A and C4B locus products. Vox Sang. 1984; 47: 362
   PubMed Web of Science ®Google Scholar
• Alper C. A., Propp R. P. Genetic polymorphism of the third component of human complement (C'3). J. Clin. Invest. 1968; 47: 2181
   PubMed Web of Science ®Google Scholar
• Chenoweth D. E., Rowe J. G., Hugh T. E. A modified method for chemotaxis under agarose. J. Immunol. Methods 1979; 25: 337
   PubMed Web of Science ®Google Scholar
• Lambris J. D., Ross G. D. Assay of membrane complement receptors (CR1 and CR2) with C3b- and C3d-coated fluorescent microspheres. J. Immunol 1982; 128: 186
   Google Scholar
• Colten H. R., Alper C. A., Rosen F. S. Genetics and biosynthesis of complement proteins. N. Engl. J. Med. 1981; 304: 653
   Google Scholar
• Colten H. R. Molecular genetics of the major histocompatibility linked complement genes. Springer Semin. Immunopathol. 1983; 6: 149
   Google Scholar
• Mahowald M. L., Dalmasso A. P., Petzel R. A., Yunis E. J. Linkage relationship of C2 deficiency, HLA and glyoxalase I loci. Vox Sang. 1979; 37: 321
   Google Scholar
• Yunis E. J., Awdeh Z. L., Raum D., Yang S. Y., Alper C. A. The MHC (major histocompatibility complex) and disease. Clinical Diagnosis and Management by Laboratory Methods, J. B. Henry. W.B. Saunders, Philadelphia 1984; 806
   Google Scholar
• Bentley D. R., Porter R. R. Isolation of cDNA clones for human complement component C2. Proc. Natl. Acad. Sci. U.S.A. 1984; 81: 1212
   Google Scholar
• Woods D. E., Edge M. D., Colten H. R. Isolation of a complementary DNA clone for the human complement protein C2 and its use in the identification of a restriction fragment length polymorphism. J. Clin. Invest. 1984; 74: 634
   PubMed Web of Science ®Google Scholar
• Carroll M. C, Campbell R. D., Bentley D. R., Porter R. R. A molecular map of the human major histocompatibility complex class III region linking complement genes C4, C2 and factor B. Nature (London) 1984; 307: 237
   PubMed Web of Science ®Google Scholar
• Muir W. A., Hedrick S., Alper C. A., Ratnoff O. D., Schacter B., Wisnieski J. J. Inherited incomplete deficiency of the fourth component of complement (C4) determined by a gene not linked to human histocompatibility leukocyte antigens. J. Clin. Invest. 1984; 74: 1509
   Google Scholar
• Alper C. A., Raum D., Karp S., Awdeh Z. L., Yunis E. J. Serum complement “supergenes” of the major histocompatibility complex in man (complotypes). Vox Sang. 1983; 45: 62
   PubMed Web of Science ®Google Scholar
• Cole F. S., Whitehead A. S., Auerbach H. S., Lint T., Zeitz H. J., Kilbridge P., Colten H. R. The molecular basis for genetic deficiency of the second component of human complement. N. Engl. J. Med. 1985; 313: 11
   PubMed Web of Science ®Google Scholar
• Mauff G., Alper C. A., Awdeh Z. L., Batchelor J. R., Bertrams J., Bruun-Petersen G., Dawkins R. L., Démant P., Edwards J., Grosse-Wilde H., Hauptmann G., Klouda P., Lamm L., Mollenhauer E., Nerl C, Olaisen B., O'Neill G., Rittner C., Roose M. H., Skanes V., Teisberg P., Wells L. Statement on the nomenclature of human C4 allotypes. Immunobiology 1983; 164: 184
   PubMed Web of Science ®Google Scholar
• Mauff G., Bender K., Giles C. M., Goldmann S., Opferkuch W., Wachauf B. Human C4 polymorphism: pedigree analysis of qualitative, quantitative, and functional parameters as a basis for phenotype interpretations. Hum. Genet. 1984; 65: 362
   PubMedGoogle Scholar
• O'Neill G. J., Yang S. Y., Tegoli J., Berger R., Dupont B. Chido and Rodgers blood groups are distinct antigenic components of human complement C4. Nature (London) 1978; 273: 668
   PubMed Web of Science ®Google Scholar
• Roos M. H., Mollenhauer E., Démant P., Rittner C. A molecular basis for the two locus model of human complement component C4. Nature (London) 1982; 298: 854
   PubMedGoogle Scholar
• Law S. K. A., Dodds A. W., Porter R. R. A comparison of the properties of two classes, C4A and C4B, of the human complement component C4. EMBO J. 1984; 3: 1819
   PubMed Web of Science ®Google Scholar
• Welch T. R., Beischel L., Berry A., Forristal J., West C. D. The effect of null C4 alleles on complement function. Clin. Immunol. Immunopathol. 1985; 34: 316
   PubMedGoogle Scholar
• Fey G., Domdey H., Wiebauer K., Whitehead A. S., Odink K. Structure and expression of the C3 gene. Springer Semin. Immunopathol. 1983; 6: 199
   Google Scholar
• Alper C. A., Rosen F. S. Studies of a hypomorphic variant of human C3. J. Clin. Invest. 1971; 50: 324
   Google Scholar
• McLean R. H., Winkelstein J. A. Genetically determined variation in the complement system: relationship to disease. J. Pediatr. 1984; 105: 179
   Google Scholar
• Arvilommi H. Capacity of complement C3 phenotypes to bind on to mononuclear cells in man. Nature (London) 1974; 251: 740
   PubMed Web of Science ®Google Scholar
• Einstein L. P., Hansen P. J., Ballow M., David A. E., Ill Davis J., Alper C. A., Rosen F. A., Colten H. R. Biosynthesis of the third component of complement (C3) in vitro by monocytes from both normal and homozygous C3-deficient humans. J. Clin. Invest. 1977; 60: 963
   PubMed Web of Science ®Google Scholar
• Ross S. C., Densen P. Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency. Medicine 1984; 63: 243
   PubMed Web of Science ®Google Scholar
• Rittner C., Bertrams J. On the significance of C2, C4, and factor B polymorphisms in disease. Hum. Genet. 1981; 56: 235
   PubMed Web of Science ®Google Scholar
• Raum D., Awdeh Z. L., Yunis E. J., Alper C. A., Gabbay K. H. Extended major histocompatibility complex haplotypes in type I diabetes mellitus. J. Clin. Invest. 1984; 74: 449
   PubMed Web of Science ®Google Scholar
• Rich S., O'Neill G., Dalmasso A. P., Nerl C, Barbosa J. Complement and HLA. Further definition of high-risk haplotypes in insulin-dependent diabetes. Diabetes 1985; 34: 504
   Google Scholar
• Carroll M. C, Campbell R. D., Porter R. R. Mapping of steroid 21-hydroxylase genes adjacent to complement component C4 genes in HLA, the major histocompatibility complex in man. Proc. Natl. Acad. Sci. U.S.A. 1985; 82: 521
   PubMed Web of Science ®Google Scholar
• White P. C, Grossberger D., Onufer B. J., Chaplin D. D., New M. I., Dupont B., Strominger J. L. Two genes encoding steroid 21-hydroxylase are located near the genes encoding the fourth component of complement in man. Proc. Natl. Acad. Sci. U.S.A. 1985; 82: 1089
   PubMed Web of Science ®Google Scholar
• O'Neill G. J., Dupont B., Pollack M. S., Levine L. S., New M. I. Complement C4 allotypes in congenital adrenal hyperplasia due to 21-hydroxylase deficiency: further evidence for different allelic variants at the 21-hydroxylase locus. Clin. Immunol. Immunopathol. 1982; 23: 312
   Google Scholar
• Fielder A. H. L., Walport M. J., Batchelor J. R., Rynes R. I., Black C. M., Dodi I. A., Hughes G. R. V. Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility. Br. Med. J. 1983; 286: 425
   PubMed Web of Science ®Google Scholar
• Gran J. T., Teisberg P., Olaissen B., Thorsby E., Husby G. HLA-B27 and allotypes of complement components in ankylosing spondylitis. J. Rheumatol 1984; 11: 324
   Google Scholar
• Dewald G., Lange C. E., Kreysel H. W. HLA-linked complement polymorphisms (C2, BF) in psoriasis. Arch. Dermatol. Res. 1983; 275: 301
   Google Scholar
• Rittner C., DeMarchi M., Mollenhauer E., Carbonara A. Coeliac disease and C4A*QO: an association secondary to HLA-DR3. Tissue Antigens 1984; 23: 130
   PubMedGoogle Scholar
• Nerl C, Mayeux R., O'Neill G. J. HLA-linked complement markers in Alzheimer's and Parkinson's disease: C4 variant (C4B2) a possible marker for senile dementia of the Alzheimer type. Neurology 1984; 34: 310
   PubMed Web of Science ®Google Scholar
• Silverstein A. M. Essential hypocomplementemia: report of a case. Blood 1960; 16: 1338
   Google Scholar
• Agnello V. Complement deficiency states. Medicine 1978; 57: 1
   PubMed Web of Science ®Google Scholar
• Alper C. A., Rosen F. S. Inherited deficiencies of complement proteins in man. Springer Semin. Immunopathol. 1984; 7: 251
   PubMed Web of Science ®Google Scholar
• Glass D., Raum D., Gibson D., Stillman J. S., Schur P. H. Inherited deficiency of the second component of complement. Rheumatic disease associations. J. Clin. Invest. 1976; 58: 853
   PubMed Web of Science ®Google Scholar
• Rynes R. I. Inherited complement deficiency states and SLE. Clin. Rheum. Dis. 1982; 8: 29
   Google Scholar
• Jordon R. E. The complement system and the skin. An overview. Arch. Dermatol. 1982; 118: 539
   Google Scholar
• Solal-Celigny P., Laviolette M., Hebert J., Atkins P. C, Sirois M., Brun G., Lehner-Netsch G., Delâge J. M. C3b inactivator deficiency with immune complex manifestations. Clin. Exp. Immunol. 1982; 47: 197
   PubMed Web of Science ®Google Scholar
• Provost T. T., Arnett F. C, Reichlin M. Homozygous C2 deficiency, lupus erythematosus, and anti-Ro (SSA) antibodies. Arthritis Rheum. 1983; 26: 1279
   PubMedGoogle Scholar
• Newman S. L., Vogler L. B., Feigin R. D., Johnston R. B., Jr. Recurrent septicemia associated with congenital deficiency of C2 and partial deficiency of factor B and the alternative complement pathway. N. Engl. J. Med. 1978; 299: 290
   PubMed Web of Science ®Google Scholar
• Schifferli J. A., Peters D. K. Complement, the immune-complex lattice, and the pathophysiology of complement-deficiency syndromes. Lancet 1983; 2: 957
   Google Scholar
• Alper C. A., Colten H. R., Rosen F. S., Rabson A. R., Macnab G. M., Gear J. S. S. Homozygous deficiency of C3 in a patient with repeated infections. Lancet 1972; ii: 1179
   Google Scholar
• Alper C. A., Abramson N., Johnston R. B., Jr., Jandl J. H., Rosen F. S. Increased susceptibility to infection associated with abnormalities of complement-mediated functions and of the third component of complement (C3). N. Engl. J. Med. 1970; 282: 349
   PubMed Web of Science ®Google Scholar
• Sjoholm A. G., Braconier J.-H., Soderstrom C. Properdin deficiency in a family with fulminant meningococcal infections. Clin. Exp. Immunol. 1982; 50: 291
   PubMed Web of Science ®Google Scholar
• Edwards K. M., Alford R., Gewurz H., Mold C. Recurrent bacterial infections associated with C3 nephritic factor and hypocomplementemia. N. Engl. J. Med. 1983; 308: 1138
   Google Scholar
• Thompson R. A., Winterborn M. H. Hypocomplementaemia due to a genetic deficiency of β1H globulin. Clin. Exp. Immunol. 1981; 46: 110
   PubMed Web of Science ®Google Scholar
• Peter G., Weigert M. B., Bissel A. R., Gold R., Kreutzer D., McLean R. H. Meningococcal meningitis in familial deficiency of the fifth component of complement. Pediatrics 1981; 67: 882
   PubMedGoogle Scholar
• Petersen B. H., Lee T. J., Snyderman R., Brooks G. F. Neisseria meningitides and Neisseria gonorrhoeae bacteremia associated with C6, C7, or C8 deficiency. Ann. Intern. Med. 1979; 90: 917
   PubMed Web of Science ®Google Scholar
• Fine D. P., Gewurz H., Griffiss M. L., Lint T. F. Meningococcal meningitis in a woman with inherited deficiency of the ninth component of complement. Clin. Immunol. Immunopathol. 1983; 28: 413
   Google Scholar
• Anderson D. C, Schmalstieg F. C, Arnaout M. A., Kohl S., Tosi M. F., Dana N., Buffone G. J., Hughes B. J., Brinkley B. R., Dickey W. D., Abramson J. S., Springer T., Boxer L. A., Hollers J. M., Smith C. W. Abnormalities of polymorphonuclear leukocyte function associated with a heritable deficiency of high molecular weight surface glycoproteins (GP138): common relationship to diminished cell adherence. J. Clin. Invest. 1984; 74: 536
   PubMed Web of Science ®Google Scholar
• Springer T. The LFA-1, Mac-1 glycoprotein family and its deficiency in an inherited disease. Fed. Proc, Fed. Am. Soc. Exp. Biol. 1985; 44: 2660
   PubMedGoogle Scholar
• Arnaout M. A., Dana N., Pitt J., Todd R. F. Ill, Deficiency of two human leukocyte surface membrane glycoproteins (Mol and LFA-1). Fed. Proc., Fed. Am. Soc. Exp. Biol. 1985; 44: 2664
   Google Scholar
• Anderson D. C, Schmalstieg F. C, Shearer W., Becker-Freeman K., Kohl S., Smith C. W., Tosi M. F., Springer T. Leukocyte LFA-1, OKM1, pl50,95 deficiency syndrome: functional and biosynthetic studies of three kindreds. Fed. Proc., Fed. Am. Soc. Exp. Biol. 1985; 44: 2671
   PubMedGoogle Scholar
• Thompson R. A., Haeney M., Reid K. B. M., Davies J. G., White R. H. R., Cameron A. H. A genetic defect of the Clq subcomponent of complement associated with childhood (immune complex) nephritis. N. Engl. J. Med. 1980; 303: 22
   PubMed Web of Science ®Google Scholar
• Hannema A. J., Kluin-Nelemans J. C, Hack C. E., Eerenberg-Belmer A. J. M., Malleé C, van Helden H. P. T. SLE like syndrome and functional deficiency of Clq in members of a large family. Clin. Exp. Immunol. 1984; 55: 106
   PubMed Web of Science ®Google Scholar
• Miller M. E., Nilsson U. R. A familial deficiency of the phagocytosis-enhancing activity of serum related to a dysfunction of the fifth component of complement (C5). N. Engl. J. Med. 1970; 282: 354
   PubMed Web of Science ®Google Scholar
• Nilsson U. R., Miller M. E., Wyman S. A functional abnormality of the fifth component of complement (C5) from human serum of individuals with a familial opsonic defect. J. Immunol. 1974; 112: 1164
   PubMedGoogle Scholar
• Agnello V., Gell J., Tye M. J. Partial genetic deficiency of the C4 component of complement is discoid lupus erythematosus and urticaria/angioedema. J. Am. Acad. Dermatol. 1983; 9: 894
   PubMed Web of Science ®Google Scholar
• Pussell B. A., Bourke E., Nayef M., Morris S., Peters D. J. Complement deficiency and nephritis. A report of a family. Lancet 1980; 1: 675
   PubMed Web of Science ®Google Scholar
• McLean R. H., Weinstein A., Damjanov I., Rothfield N. Hypomorphic variant of C3, arthritis, and chronic glomerulonephritis. J. Pediatr. 1978; 93: 937
   Google Scholar
• Wyatt R. J., Julian B. A., Weinstein A., Rothfield N. F., McLean R. H. Partial H (β1H) deficiency and glomerulonephritis in two families. J. Clin. Immunol. 1982; 2: 110
   PubMed Web of Science ®Google Scholar
• Marder H. K., Coleman T. H., Forristal J., Beischel L., West C. D. An inherited defect in the C3 convertase, C3b,Bb, associated with glomerulonephritis. Kidney Int. 1983; 23: 749
   Google Scholar
• Donaldson V. H., Evans R. R. A biochemical abnormality in hereditary angioneurotic edema. Absence of serum inhibitor of C'1-esterase. Am. J. Med. 1963; 35: 37
   PubMed Web of Science ®Google Scholar
• Frank M. M., Gelfand J. A., Atkinson J. P. Hereditary angioedema: the clinical syndrome and its management. Ann. Intern. Med. 1976; 84: 580
   PubMed Web of Science ®Google Scholar
• Gelfand J. A. The role of complement in urticaria and angioedema. Clin. Immunol. Rev. 1981; 1: 257, 1982
   Google Scholar
• Gelfand J. A., Sherins R. J., Alling D. W., Frank M. M. Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities. N. Engl. J. Med. 1976; 295: 1444
   PubMed Web of Science ®Google Scholar
• Donaldson V. H., Harrison R. A., Rosen F. S., Bing D. H., Kindness G., Canar J., Wagner C. J., Awad S. Variability in purified dysfunctional Cl-inhibitor proteins from patients with hereditary angioneurotic edema. Functional and analytical gel studies. J. Clin. Invest. 1985; 75: 124
   PubMed Web of Science ®Google Scholar
• Blumenthal M. N., Dalmasso A. P., Roitman B., Kelly J., Noreen H., Emmy L., Mendell N. R., Yunis E. J. Lack of linkage between hereditary angioedema and the A and B loci of the HLA system. Vox Sang. 1978; 35: 132
   Google Scholar
• Fong J. S., Good R. A., Gewurz H. A simple diagnostic test for hereditary angioneurotic edema. J. Lab. Clin. Med. 1970; 76: 836
   Google Scholar
• Caldwell J. R., Ruddy S., Schur P. H., Austen K. F. Acquired C1 inhibitor deficiency in lymphosarcoma. Clin. Immunol. Immunopathol. 1972; 1: 39
   Google Scholar
• Gelfand J. A., Boss G. R., Conley C. L., Reinhart R., Frank M. M. Acquired C1 esterase inhibitor deficiency and angioedema: a review. Medicine 1979; 58: 321
   PubMed Web of Science ®Google Scholar
• Geha R. S., Quinti I., Austen K. F., Cicardi M., Sheffer A., Rosen F. S. Acquired Cl-inhibitor deficiency associated with antiidiotypic antibody to monoclonal immunoglobulins. N. Engl. J. Med. 1985; 312: 534
   PubMed Web of Science ®Google Scholar
• Dixon F. J., Feldman J. D., Vazquez J. J. Experimental glomerulonephritis. The pathogenesis of a laboratory model resembling the spectrum of human glomerulonephritis. J. Exp. Med. 1961; 113: 899
   PubMed Web of Science ®Google Scholar
• Lawley T. J., Bielory L., Gascon P., Yancey K. B., Young N. S., Frank M. M. A prospective clinical and immunological analysis of patients with serum sickness. N. Engl. J. Med. 1984; 311: 1407
   PubMed Web of Science ®Google Scholar
• Miyakawa Y., Yamada A., Kosaka K., Tsuda F., Kosugi E., Mayumi M. Defective immune-adherence (C3b) receptor on erythrocytes from patients with systemic lupus erythematosus. Lancet 1981; 2: 493
   PubMed Web of Science ®Google Scholar
• Iida K., Mornaghi R., Nussenzweig V. Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus. J. Exp. Med. 1982; 155: 1427
   PubMed Web of Science ®Google Scholar
• Minota S., Terai C, Nojima Y., Takano K., Takai E., Miyakawa Y., Takaku F. Low VC C3b receptor reactivity on erythrocytes from patients with systemic lupus erythematosus detected by immune adherence hemagglutination and radioimmunoassays with monoclonal antibody. Arthritis Rheum. 1984; 27: 1329
   PubMed Web of Science ®Google Scholar
• Ross G. D., Yount W. J., Walport M. J., Winfield J. B., Parker C. J., Fuller C. R., Taylor R. P., Myones B. L., Lachmann P. J. Disease-associated loss of erythrocyte complement receptors (CR, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation. J. Immunol. 1985; 135: 2005
   PubMed Web of Science ®Google Scholar
• Waldo F. B., Forristal J., Beischel L., West C. D. A circulating inhibitor of fluid-phase amplification. C3 convertase formation in systemic lupus erythematosus. J. Clin. Invest. 1985; 75: 1786
   Google Scholar
• Aguado M. T., Penin L. H., Miescher P. A., Lambert P. H. Decreased capacity to solubilize immune complexes in sera from patients with systemic lupus erythematosus. Arthritis Rheum. 1981; 24: 1225
   Google Scholar
• Schifferli J. A., Morris S. M., Dash A., Peters D. K. Complement-mediated solubilization in patients with systemic lupus erythematosus, nephritis or vasculitis. Clin. Exp. Immunol. 1981; 46: 557
   PubMed Web of Science ®Google Scholar
• Naama J. K., Mitchell W. S., Zoma A., Veitch J., Whaley K. Complement-mediated inhibition of immune precipitation in patients with immune complex diseases. Clin. Exp. Immunol. 1983; 51: 292
   PubMedGoogle Scholar
• Naama J. K., Mitchell W. S., Whaley K. Inhibition of complement-mediated solubilization of antigen-antibody complexes by sera from patients with rheumatoid arthritis. Clin. Exp. Immunol. 1983; 54: 429
   Google Scholar
• Baatrup G., Petersen I., Kappelgaard E., Jepsen H. H., Svehag S. E. Complement-mediated solubilization of immune complexes. Solubilization inhibition and complement factor levels in SLE patients. Clin. Exp. Immunol. 1984; 55: 313
   Google Scholar
• Vaughan J. H., Bayles T. B., Favour C. B. The response of serum gamma globulin level and complement titer to adrenocorticotropic hormone (ACTH) therapy in lupus erythematosus disseminatus. J. Lab. Clin. Med. 1951; 37: 698
   PubMed Web of Science ®Google Scholar
• Schur P. H. Complement and lupus erythematosus. Arthritis Rheum. 1982; 25: 793
   Google Scholar
• Gewurz H., Pickering R. J., Mergenhagen S. E., Good R. A. The complement profile in acute glomerulonephritis, systemic lupus erythematosus and hypocomplementic chronic glomerulonephritis. Contrasts and experimental correlations. Int. Arch. Allergy 1968; 34: 556
   Web of Science ®Google Scholar
• Lewis E. J. Patterns of circulating complement in renal diseases. Annu. Rev. Med. 1979; 30: 445
   Google Scholar
• Lloyd W., Schur P. H. Immune complexes, complement, and anti-DNA in exacerbations of systemic lupus erythematosus (SLE). Medicine 1981; 60: 208
   PubMed Web of Science ®Google Scholar
• Hashimoto Y., Ziff M., Hurd E. R. Increased endothelial cell adherence, aggregation, and superoxide generation by neutrophils incubated in systemic lupus erythematosus and Felty's syndrome sera. Arthritis Rheum. 1982; 25: 1409
   PubMed Web of Science ®Google Scholar
• Given W. P., Edelson H. S., Kaplan H. B., Aisen P., Weissmann G., Abramson S. B. Generation of C5-derived peptides and other immune reactants in the sera of patients with systemic lupus erythematosus. Arthritis Rheum. 1984; 27: 631
   PubMed Web of Science ®Google Scholar
• Sturfelt G., Sjoholm A. G. Complement components, complement activation, and acute phase response in systemic lupus erythematosus. Int. Arch. Allergy Appl. Immunol. 1984; 75: 75
   PubMedGoogle Scholar
• Hecht B., Siegel N., Adler M., Kashgarian M., Hayslett J. P. Prognostic indices in lupus nephritis. Medicine 1976; 55: 163
   PubMed Web of Science ®Google Scholar
• Valle R. R., Eaton R. B., Schnneider G., Schur P. H. Complement activation by antibodies to DNA in systemic lupus erythematosus measured by enzyme immunoassay. Clin. Immunol. Im-munopathol. 1985; 34: 345
   Google Scholar
• Jarrett M. P., Sablay L. B., Walter L., Barland P., Grayzel A. I. The effect of continuous normalization of serum hemolytic complement on the course of lupus nephritis. A five year prospective study. Am. J. Med. 1981; 70: 1067
   PubMed Web of Science ®Google Scholar
• Lockshin M. D., Harpel P. C, Druzin M. L., Becker C. G., Klein R. F., Watson R. M., Elkon K. B., Reinitz E. Lupus pregnancy. II. Unusual pattern of hypocomplementemia and thrombocytopenia in the pregnant patient. Arthritis Rheum. 1985; 28: 58
   Google Scholar
• Hunder G. G., Mullen B. J., McDuffie F. C. Complement in pericardial fluid of lupus erythematosus. Studies in two patients. Ann. Intern. Med. 1974; 80: 453
   Google Scholar
• Sim E., Gill E. W., Sim R. B. Drugs that induce systemic lupus erythematosus inhibit complement C4. Lancet 1984; 2: 422
   PubMedGoogle Scholar
• Elson C. J., Carter S. D., Cottrell B. J., Scott D. G. I., Bacon P. A., Wallington T. B. Complement activating properties of complexes containing rheumatoid factor in synovial fluids and sera from patients with rheumatoid arthritis. Clin. Exp. Immunol. 1985; 59: 285
   Google Scholar
• Morrow W. J. W., Williams D. J. P., Ferec, Casburn-Budd R., Isenberg D. A., Pake E., Snaith M. L., Youinou P., Le Goff P. The use of C3d as a means of monitoring clinical activity in systemic lupus erythematosus and rheumatoid arthritis. Ann. Rheum. Dis. 1983; 42: 668
   PubMed Web of Science ®Google Scholar
• Kapp A., Meske-Brand S., Maly F. E., Müller W. Komplementaktivierung bei Patienten mit chronischer Polyarthritis, gemessen anhand des Komplementbruchstückes C3a im Plasma. Z. Rheumatol. 1984; 43: 103
   Google Scholar
• Schur P. H. Complement studies of sera and other biologic fluids. Hum. Pathol 1983; 14: 338
   PubMedGoogle Scholar
• Bunch T. W., Hunder G. G., Offord K., McDuffie F. C. Synovial fluid complement: usefulness in diagnosis and classification of rheumatoid arthritis. Ann. Intern. Med. 1974; 81: 32
   PubMed Web of Science ®Google Scholar
• Lawley T. J., Frank M. M. Immune complexes and immune complex diseases. Clinical Immunology, C. W. Parker. W.B. Saunders, Philadelphia 1980; 143
   Google Scholar
• Gelfand M. C, Shin M. L., Nagle R. B., Green I., Frank M. M. The glomerular complement receptor in immunologically mediated renal glomerular injury. N. Engl. J. Med. 1976; 295: 10
   PubMed Web of Science ®Google Scholar
• Verroust P. J., Wilson C. B., Cooper N. R., Edgington T. S., Dixon F. J. Glomerular complement components in human glomerulonephritis. J. Clin. Invest. 1974; 53: 77
   Google Scholar
• Raij L., Michael A. F. Immunologic aspects of kidney disease. Clinical Immunology, C. W. Parker. W.B. Saunders, Philadelphia 1980; 1051
   Google Scholar
• Endre Z. H., Pussell B. A., Charlesworth J. A., Coovadia H. M., Seedat Y. K. C3 metabolism in acute glomerulonephritis: implications for sites of complement activation. Kidney Int. 1984; 25: 937
   Google Scholar
• Biesecker G., Katz S., Koffler D. Renal localization of the membrane attack complex in systemic lupus erythematosus nephritis. Exp. Med. 1981; 154: 1779
   PubMed Web of Science ®Google Scholar
• Falk R. J., Dalmasso A. P., Kim Y., Tsai C. H., Scheinman J. I., Gewurz H., Michael A. F. Neoantigen of the polymerized ninth component of complement. Characterization of a monoclonal antibody and immunohistochemical localization in renal disease. J. Clin. Invest. 1983; 72: 560
   PubMed Web of Science ®Google Scholar
• Muso E., Sekita K., Doi T., Kuwahara T., Yoshida H., Tamura T., Kawai C, Hamashima Y. Immunopathological correlation between mesangial C3d-deposition and C3d-fixing circulating immune complexes in lupus nephritis. Clin. Immunol. Immunopathol. 1984; 32: 351
   PubMedGoogle Scholar
• Vallota E. H., Forristal J., Davis N. C, West C. D. The C3 nephritic factor and membran-oproliferative nephritis: correlation of serum levels of nephritic factor with C3 levels, with therapy, and with progression of the disease. J. Pediatr. 1972; 80: 947
   Google Scholar
• Schena F. P., Pertosa G., Stanziale P., Vox E., Pecoraro C, Andreucci V. E. Biological significance of the C3 nephritic factor in membranoproliferative glomerulonephritis. Clin. Nephrol. 1982; 18: 240
   Google Scholar
• Sissons J. G. P., West R. J., Fallows J., Williams D. G., Boucher B. J., Amos N., Peters D. K. The complement abnormalities of lipodystrophy. N. Engl. J. Med. 1976; 294: 461
   PubMed Web of Science ®Google Scholar
• Coleman T. H., Forristal J., Kosaka T., West C. D. Inherited complement component deficiencies in membranoproliferative glomerulonephritis. Kidney Int. 1983; 24: 681
   Google Scholar
• Doi T., Kanatsu K., Nagai H., Suehiro F., Kuwahara T., Hamashima Y. Demonstration of C3d deposits in membranous nephropathy. Nephron 1984; 37: 232
   Google Scholar
• Sjöholm A. G., Brun C, Larsen S., Thysell H. Circulating immune complexes and C1 activation in patients with rapidly progressive glomerulonephritis, before and after treatment with immunosuppression and plasma exchange. Int. Arch. Allergy Appl. Immunol. 1983; 72: 9
   Google Scholar
• Egido J., Sancho J., Blasco R., Rivera F., Hernando L. Immunopathogenetic aspects of IgA nephropathy. Adv. Nephrol. 1983; 12: 103
   Google Scholar
• Miyazaki R., Kuroda M., Akiyama T., Otani I., Tofuku Y., Takeda R. Glomerular deposition and serum levels of complement control proteins in patients with IgA nephropathy. Clin. Nephrol. 1984; 21: 335
   Google Scholar
• Tomino Y., Sakai H., Nomoto Y., Endoh M., Arimori S., Fujita T. Deposition of C4-binding protein and β,H globulin in kidneys of patients with IgA nephropathy. Tokai J. Exp. Clin. Med. 1981; 6: 217
   Google Scholar
• Julian B. A., Wyatt R. J., McMorrow R. G., Galla J. H. Serum complement proteins in IgA nephropathy. Clin. Nephrol. 1983; 20: 251
   PubMed Web of Science ®Google Scholar
• Nicholls K., Kincaid-Smith P. Defective in vivo Fc-and C3b-receptor function in IgA nephropathy. Am. J. Kidney Dis. 1984; 4: 128
   Google Scholar
• Cordonnier D., Vialtel P., Renversez J. C, Chenais F., Favre M., Tournoud A., Barioz C, Bayle F., Dechelette E., Denis M. C, Couderc P. Renal diseases in 18 patients with mixed type II IgM-IgG cryoglobulinemia: monoclonal lymphoid infiltration (2 cases) and membranoproliferative glomerulonephritis (14 cases). Adv. Nephrol. 1983; 12: 177
   PubMedGoogle Scholar
• Gonzalo A., Mampaso F., Gallego N., Bellas C, Segui J., Ortuno J. Hemolytic uremic syndrome with hypocomplementemia and deposits of IgM and C3 in the involved renal tissue. Clin. Nephrol. 1981; 16: 193
   Google Scholar
• Chiu F. J., Atkin C. L. Catabolites of the third component of complement in urines of hereditary nephritis patients. J. Biol. Chem. 1983; 258: 7200
   Google Scholar
• Atkinson J. P., Rosse W. F. Immunohematology. Clinical Immunology, C. W. Parker. W.B. Saunders, Philadelphia 1980; 930
   Google Scholar
• Petz L. D., Garratty G. Acquired Immune Hemolytic Anemias. Churchill Livingstone, New York 1980
   Google Scholar
• Nydegger U. E., Kazatchkine M. D. The role of complement in immune clearance of blood cells. Springer Semin. Immunopathol. 1983; 6: 373
   PubMed Web of Science ®Google Scholar
• Nicholson-Weller A., March J. P., Rosenfeld S. I., Austen K. F. Affected erythrocytes of patients with paroxysmal nocturnal hemoglobulinuria are deficient in the complement regulatory protein, decay accelerating factor. Proc. Natl. Acad. Sci. U.S.A. 1983; 80: 5066
   PubMed Web of Science ®Google Scholar
• Pangburn M. K., Schreiber R. D., Müller-Eberhard H. J. Deficiency of an erythrocyte membrane protein with complement regulatory activity in paroxysmal nocturnal hemoglobinuria. Proc. Natl. Acad. Sci. U.S.A. 1983; 80: 5430
   PubMed Web of Science ®Google Scholar
• Salama A., Bhakdi S., Mueller-Eckhardt C., Kayser W. Deposition of the terminal C5b-9 complement complex on erythrocytes by human red cell autoantibodies. Br. J. Haematol. 1983; 55: 161
   PubMed Web of Science ®Google Scholar
• Kerr R. O., Cardamone J., Dalmasso A. P., Kaplan M. E. Two mechanisms of erythrocyte destruction in penicillin-induced hemolytic anemia. N. Engl. J. Med. 1972; 287: 1322
   PubMed Web of Science ®Google Scholar
• Lalezari P. Neutrophil antigens. Immunology and clinical implications. The Granulocyte: Function and Clinical Utilization, T. Greenwalt, G. A. Jamieson. Alan R. Liss, New York 1982; 209
   Google Scholar
• Rustagi P. K., Currie M. S., Logue G. L. Activation of human complement by immunoglobulin G antigranulocyte antibody. J. Clin. Invest. 1982; 70: 1137
   Google Scholar
• Myers T. J., Kim B. K., Steiner M., Baldini M. G. Platelet-associated complement C3 in immune thrombocytopenic purpura. Blood 1982; 59: 1023
   Google Scholar
• Parker C. J., Baker P. J., Rosse W. F. Increased enzymatic activity of the alternative pathway convertase when bound to the erythrocytes of paroxysmal nocturnal hemoglobinuria. J. Clin. Invest. 1982; 69: 337
   PubMed Web of Science ®Google Scholar
• Nicholson-Weller A., Spicer D. B., Austen K. F. Deficiency of the complement regulatory protein, “decay-accelerating factor,” on membranes of granulocytes, monocytes, and platelets in paroxysmal nocturnal hemoglobinuria. N. Engl. J. Med. 1985; 312: 1091
   PubMed Web of Science ®Google Scholar
• Packman C. H., Rosenfeld S. I., Jenkins D. E., Jr., Thiem P. A., Leddy J. P. Complement lysis of human erythrocytes. Differing susceptibility of two types of paroxysmal nocturnal hemoglobinuria cells to C5b-9. J. Clin. Invest. 1979; 64: 428
   Google Scholar
• Dalmasso A. P., Pizzimenti M. C, Vacs E., Diaz A. Abnormal solubilization by Triton X-100 of erythrocyte membranes from patients with paroxysmal nocturnal hemoglobinuria. Proc. Soc. Exp. Biol. Med. 1974; 147: 273
   Google Scholar
• Drew J. H., Arroyave C. M. Complement activation: use in the diagnosis of infection in newborn infants. Acta Paediatr. Scand. 1981; 255: 70
   Google Scholar
• Adinolfi M. Human complement C9 and factor B in the diagnosis of infections in infants. Acta Paediatr. Scand. 1982; 71: 845
   Google Scholar
• Coonrod J. D., Rylko-Bauer B. Complement levels in pneumococcal pneumonia. Infect. Immun. 1977; 18: 14
   PubMedGoogle Scholar
• Prober C. G., Frayha H., Klein M., Schiffman G. Immunologic responses of children to serious infections with Streptococcus pneumoniae. J. Infect. Dis. 1983; 148: 427
   PubMedGoogle Scholar
• Greenwood B. M., Onyewotu I. I., Whittle H. C. Complement and meningococcal infection. Br. Med. J. 1976; 1: 797
   Google Scholar
• Füst G., Petrás G., Ujhelyi E. Activation of the complement system during infections due to gram-negative bacteria. Clin. Immunol. Immunopathol. 1976; 5: 293
   PubMedGoogle Scholar
• Fearon D. T., Ruddy S., Schur P. H., McCabe W. R. Activation of the properdin pathway of complement in patients with gram-negative bacteremia. N. Engl. J. Med. 1975; 292: 937
   PubMed Web of Science ®Google Scholar
• Bessa S. M., Dalmasso A. P., Goodale R. L., Jr. Studies on the mechanism of endotoxin-induced increase of alveolocapillary permeability. Proc. Soc. Exp. Biol. Med. 1974; 147: 701
   Web of Science ®Google Scholar
• Fromkes J. J., Thomas F. B., Kraut E. H. Activation of the alternative complement pathway in ascitic fluid during spontaneous bacterial peritonitis. J. Clin. Gastroenterol. 1982; 4: 347
   PubMed Web of Science ®Google Scholar
• Suter S., Berger D., Despont J. P., Waldvogel F. Low levels of functional of α1,-proteinase inhibitor in the promotion of C3-cleavage by granulocyte-neutral proteases in pleural empyema. J. Infect. Dis. 1984; 149: 935
   Google Scholar
• de Azevedo M. P., de Melo P. H. A comparative study of the complementary activity of serum in the polar forms of leprosy and in the leprosy reaction. Int. J. Lepr. 1966; 34: 34
   Google Scholar
• Valentijn R. M., Faber W. R., Lai A, Fat R. F. M., Chan Pin, Jie J. C, Daha M. R., van Es L. A. Immune complexes in leprosy patients from an endemic and a nonendemic area and a longitudinal study of the relationship between complement breakdown products and the clinical activity of erythema nodosum leprosum. Clin. Immunol. Immunopathol. 1982; 22: 194
   Google Scholar
• Cheson B. D., Walker H. S., Heath M. E., Gobel J., Janatova J. Defective binding of the third component of complement (C3) to Streptococcus pneumoniae in multiple myeloma. Blood 1984; 63: 949
   Google Scholar
• Corry J. M., Polhill R. B., Edmonds S. R., Johnston R. B. Activity of the alternative complement pathway after splenectomy: comparison to activity in sickle cell disease and hypogammaglobulinemia. J. Pediatr. 1979; 95: 964
   Google Scholar
• Wilson W. A. Nature of complement deficiency in sickle cell disease. Arch. Dis. Child. 1983; 58: 235
   Google Scholar
• Wilson W. A., Thomas E. J., Sissons J. G. P. Complement activation in asymptomatic patients with sickle cell aneamia. Clin. Exp. Immunol. 1979; 36: 130
   PubMed Web of Science ®Google Scholar
• Lanng Nielsen J., Buskjaer L., Lamm L. U., Soiling J., Ellegaard J. Complement studies in splenectomized patients. Scand. J. Haematol. 1983; 30: 194
   Google Scholar
• Cooper N. R., Jensen F. C, Welsh R. M., Jr., Oldstone M. B. A. Lysis of RNA tumor viruses by human serum: direct antibody-independent triggering of the classical complement pathway. J. Exp. Med. 1976; 144: 970
   PubMed Web of Science ®Google Scholar
• Hoshino H., Tanaka H., Miwa M-, Okada H. Human T-cell leukaemia virus is not lysed by human serum. Nature (London) 1984; 310: 324
   PubMed Web of Science ®Google Scholar
• de Bracco M. M. E., Rimoldi M. T., Cossio P. M., Rabinovich A., Maiztegui J. I., Carballal G., Arana R. M. Argentine hemorrhagic fever. Alterations of the complement system and anti-Junin-virus humoral response. N. Engl. J. Med. 1978; 299: 216
   PubMed Web of Science ®Google Scholar
• Suvatte V., Pongpipat D., Tuchinda S., Ratanawongs A., Tuchinda P., Bukkavesa S. Studies on serum complement C3 and fibrin degradation products in Thai hemorrhagic fever. J. Med. Assoc. Thailand 1973; 56: 24
   Google Scholar
• Baer G. M., Walker J. A., Yager P. A. Studies of an outbreak of acute hepatitis A. I. Complement level fluctuation. J. Med. Virol. 1977; 1: 1
   Google Scholar
• Charlesworth J. A., Lawrence S., Worsdall P. A., Roy L. P., Boughton C. R. Acute hepatitis. Significance of changes in complement components. Clin. Exp. Immunol. 1977; 28: 496
   Google Scholar
• Charlesworth J. A., Pussell B. A., Roy L. P., Robertson M. R., Beveridge J. Measles infection. Involvement of the complement system. Clin. Exp. Immunol. 1976; 24: 401
   PubMed Web of Science ®Google Scholar
• Joseph B. S., Cooper N. R., Oldstone M. B. A. Immunologic injury of cultured cells infected with measles virus. I. Role of IgG antibody and the alternative complement pathway. J. Exp. Med. 1975; 141: 761
   PubMedGoogle Scholar
• Charlesworth J. A., Pussell B. A., Roy L. P., Lawrence S., Robertson M. R. The complement system in infectious mononucleosis. Aust. N. Z. J. Med. 1977; 7: 23
   Google Scholar
• Pickering R. J., Urizar R. E., Hanson P. A., Laffin R. J. Abnormalities of the complement system in Reye syndrome. J. Pediatr. 1979; 94: 218
   Google Scholar
• Greenwood B. M., Brueton M. J. Complement activation in children with acute malaria. Clin. Exp. Immunol. 1974; 18: 267
   PubMed Web of Science ®Google Scholar
• Srichaikul T., Puwasatien P., Karnjanajetanee J., Bokisch V. A. Complement changes and disseminated intravascular coagulation in Plasmodium falciparum malaria. Lancet 1975; 1: 770
   PubMed Web of Science ®Google Scholar
• Phanuphak P., Hanvanich M., Sakulramrung R., Moollaor P., Sitprija V., Phanthumkosol D. Complement changes in falciparum malaria infection. Clin. Exp. Immunol. 1985; 59: 571
   Google Scholar
• Ward P. A., Kibukamusoke J. W. Evidence for soluble immune complexes in the pathogenesis of the glomerulonephritis of quartan malaria. Lancet 1969; 1: 283
   PubMed Web of Science ®Google Scholar
• Neva F. A., Howard W. A., Glew R. H., Krotoski W. A., Gam A. A., Collins W. E., Atkinson J. P., Frank M. M. Relationship of serum complement levels to events of the malarial paroxysm. J. Clin. Invest. 1974; 54: 451
   Google Scholar
• Greenwood B. M., Whittle H. C. Complement activation in patients with Gambian sleeping sickness. Clin. Exp. Immunol. 1976; 24: 133
   Google Scholar
• Budzko D. B., Pizzimenti M. C., Kierszenbaum F. Effects of complement depletion in experimental Chagas' disease: immune lysis of virulent blood forms of Trypanosoma cruzi. Infect. Immun. 1975; 11: 86
   PubMed Web of Science ®Google Scholar
• Dalmasso A. P., Jarvinen J. A. Experimental Chagas' disease in complement-deficient mice and guinea pigs. Infect. Immun. 1980; 28: 434
   Google Scholar
• Madwar M. A., O'Shea J. M., Skelton J. A., Soothill J. F. Complement components and immunoglobulins in patients with schistosomiasis. Clin. Exp. Immunol. 1978; 34: 354
   Google Scholar
• Machado A. J., Gazzinelli G., Pellegrino J., Dias da Silva W. Schistosoma mansoni: the role of the complement C3-activating system in the cercaricidal action of normal serum. Exp. ParasitoL 1975; 38: 20
   Google Scholar
• Greenblatt H. C, Eveland L. K., Morse S. I. Schistosoma mansoni: complement and cercarial tail loss during in vitro transformation. Exp. ParasitoL 1979; 48: 100
   Google Scholar
• Santoro F., Lachmann P. J., Capron A., Capron M. Activation of complement by Schistosoma mansoni schistosomula: killing of parasites by the alternative pathway and requirement of IgG for classical pathway activation. J. Immunol. 1979; 123: 1551
   Google Scholar
• Anwar A. R. E., Smithers S. R., Kay A. B. Killing of schistosomula of Schistosoma mansoni coated with antibody and/or complement by human leukocytes in vitro: requirement for complement in preferential killing by eosinophils. J. Immunol. 1979; 122: 628
   PubMed Web of Science ®Google Scholar
• Ottesen E. A., Stanley A. M., Gelfand J. A., Gadek J. E., Frank M. M., Nash T. E., Cheever A. W. Immunoglobulin and complement receptors on human eosinophils and their role in cellular adherence to schistosomules. Am. J. Trop. Med. Hyg. 1977; 134, Suppl. 26
   Google Scholar
• Marx J. J., Jr., Flaherty D. K. Activation of the complement sequence by extracts of bacteria and fungi associated with hypersensitivity pneumonitis. J. Allergy Clin. Immunol. 1976; 57: 328
   PubMed Web of Science ®Google Scholar
• de Bracco M. M. E., Budzko D. B., Negroni R. Mechanisms of activation of complement by extracts of Aspergillus fumigatus. Clin. Immunol. Immunopathol. 1976; 5: 333
   PubMedGoogle Scholar
• Sohnle P. G., Frank M. M., Kirkpatrick C. H. Deposition of complement components in the cutaneous lesions of chronic mucocutaneous candidiasis. Clin. Immunol. Immunopathol. 1976; 5: 340
   Google Scholar
• Laxalt K. A., Kozel T. R. Chemotaxigenesis and activation of the alternative complement pathway by encapsulated and non-encapsulated Cryptococcus neoformans. Infect. Immun. 1979; 26: 435
   PubMed Web of Science ®Google Scholar
• Macher A. M., Bennett J. E., Gadek J. E., Frank M. M. Complement depletion in crypto-coccal sepsis. J. Immunol 1978; 120: 1686
   PubMed Web of Science ®Google Scholar
• Jordon R. E., Schroeter A. L., Rogers R. S., Perry H. O. Classical and alternate pathway activation of complement in pemphigus vulgaris lesions. J. Invest. Dermatol 1974; 63: 256
   Google Scholar
• Singer K. H., Hashimoto K., Jensen P. J., Morioka S., Lazarus G. S. Pathogenesis of autoimmunity in pemphigus. Annu. Rev. Immunol. 1985; 3: 87
   Google Scholar
• Jortion R. E. Complement activation in pemphigus and bullous pemphigoid. J. Invest. Dermatol. 1976; 67: 366
   Google Scholar
• Dahl M. V., Falk R. J., Carpenter R., Michael A. F. Deposition of the membrane attack complex of complement in bullous pemphigoid. J. Invest. Dermatol. 1984; 82: 132
   Google Scholar
• Dahl M. V., Falk R. J., Carpenter R., Michael A. F. Membrane attack complex of complement in dermatitis herpetiformis. Arch. Dermatol. 1985; 121: 70
   Google Scholar
• Marley W. M., Spitzer R. E., Belew P. W., Stitzel A. E., Rosenberg E. W. Serial studies of complement proteins in psoriasis. J. Invest. Dermatol. 1982; 78: 346
   Google Scholar
• Lim H. W., Poh-Fitzpatrick M. B., Gigli I. Activation of the complement system in patients with porphyrias after irradiation in vivo. J. Clin. Invest. 1984; 74: 1961
   PubMed Web of Science ®Google Scholar
• Lim H. W., Gigli I. The role of complement in phototoxic reactions. Springer Semin. Immunopathol. 1981; 4: 209
   Google Scholar
• Clemmensen O. J., Staberg B., Worm A. M. Activation of complement in the skin after PUVA therapy. Acta Derm. Venereol. (Stockholm) 1984; 64: 5
   Google Scholar
• Sundsmo J. S., Papin R. A., Wood L., Hirani S., Waldeck N., Buckingham B., Kershnar A., Ascher M., Charles M. A. Complement activation in type 1 human diabetes. Clin. Immunol. Immunopathol. 1985; 35: 211
   Google Scholar
• Charlesworth J. A., Campbell L. V., Catanzaro R., Pussell B. A., Pasterfield G. V., Peake P. Immune complexes in diabetes mellitus: studies of complement utilisation and tissue deposition. J. Lab. Clin. Immunol 1982; 8: 163
   Google Scholar
• Rich S. S., Dalmasso A. P., O'Neill G., Barbosa J. HLA, complement, extended haplotypes and risk for insulin-dependent diabetes (IDD). Diabetes 1984; 33: 83A
   Google Scholar
• Barnett A. H., Mijovic C, Fletcher J., Chesner I., Kulkuska-Langlands B. M., Holder R., Bradwell A. R. Low plasma C4 concentrations: association with microangiopathy in insulin dependent diabetes. Br. Med. J. 1984; 289: 943
   Google Scholar
• Ruuska P., Ilonen J., Mustonen A., Tiilikainen A. Defective erythrocyte C3b receptor function associated with low serum complement (C3, C4) concentrations in insulin-dependent diabetes mellitus. Ciin. Exp. Immunol. 1984; 57: 12
   Google Scholar
• Jans H., Heltberg A., Zeeberg I., Halkjaer Kristensen J., Fog T., Raun N. E. Immune complexes and the complement factors C4 and C3 in cerebrospinal fluid and serum from patients with chronic progressive multiple sclerosis. Acta Neurol Scand. 1984; 69: 34
   PubMed Web of Science ®Google Scholar
• Vanguri P., Koski C. L., Silverman B., Shin M. L. Complement activation by isolated myelin: activation of the classical pathway in the absence of myelin-specific antibodies. Proc. Natl. Acad. Sci. U.S.A. 1982; 79: 3290
   Google Scholar
• Cyong J. C, Witkin S. S., Rieger B., Barbarese E., Good R. A., Day N. K. Antibody-independent complement activation by myelin via the classical complement pathway. J. Exp. Med. 1982; 155: 587
   Google Scholar
• Donnenfeld H., Kascsak R. J., Bartfeld H. Deposits of IgG and C3 in the spinal cord and motor cortex of ALS patients. J. Neuroimmunol. 1984; 6: 51
   PubMed Web of Science ®Google Scholar
• Koski C. L., Humphrey R., Shin M. L. Anti-peripheral myelin antibody in patients with demyelinating neuropathy: quantitative and kinetic determination of serum antibody by complement component 1 fixation. Proc. Natl. Acad. Sci. U.S.A. 1985; 82: 905
   PubMed Web of Science ®Google Scholar
• Ishii T., Haga S. Immuno-electron-microscopic localization of complements in amyloid fibrils of senile plaques. Acta NeuropathoJ. (Berlin) 1984; 63: 296
   PubMed Web of Science ®Google Scholar
• Horn J. K., Ranson J. H.C, Ong R., Poulis D., Perez H. D., Goldstein I. M. Complement catabolism and chemotaxis in acute pancreatitis. J. Surg. Res. 1982; 32: 569
   PubMed Web of Science ®Google Scholar
• Perez H. D., Horn J. K., Ong R., Goldstein I. M. Complement (C5)-derived chemotactic activity in serum from patients with pancreatitis. J. Lab. Clin. Med. 1983; 101: 123
   PubMedGoogle Scholar
• Whicher J. T., Barnes M. P., Brown A., Cooper M. J., Read R., Walters G., Williamson R. C. N. Complement activation and complement control proteins in acute pancreatitis. Gut 1982; 23: 944
   PubMed Web of Science ®Google Scholar
• Foulis A. K., Murray W. R., Galloway D., McCartney A. C, Lang E., Veitch J., Whaley K. Endotoxaemia and complement activation in acute pancreatitis in man. Gut 1982; 23: 656
   PubMed Web of Science ®Google Scholar
• Lindgren S., Laurell A. B., Eriksson S. Complement components and activation in primary biliary cirrhosis. Hepatology 1984; 4: 9
   PubMed Web of Science ®Google Scholar
• Thomas H. C., Potter B. J., Elias E., Sherlock S. Metabolism of the third component of complement in acute type B hepatitis, HBs antigen positive glomerulonephritis, polyarteritis nodosum, and HBs antigen positive and negative chronic active liver disease. Gastroenterology 1979; 76: 673
   PubMedGoogle Scholar
• Lindgren S., Eriksson S. IgM in primary biliary cirrhosis. Physicochemical and complement activating properties. J. Lab. Clin. Med. 1982; 99: 636
   PubMed Web of Science ®Google Scholar
• Munoz L. E., De Villiers D., Markham D., Whaley K., Thomas H. C. Complement activation in chronic liver disease. Clin. Exp. Immunol. 1982; 47: 548
   PubMed Web of Science ®Google Scholar
• Lake A. M., Stitzel A. E., Urmson J. R., Walker W. A., Spitzer R. E. Complement alterations in inflammatory bowel disease. Gastroenterology 1979; 76: 1374
   PubMed Web of Science ®Google Scholar
• Elmgreen J., Berkowicz A., Sorensen H. Defective release of CSa related chemo-attractant activity from complement in Crohn's disease. Gut 1983; 24: 525
   PubMed Web of Science ®Google Scholar
• Elmgreen J., Both H., Binder V. Familial occurrence of complement dysfunction in Crohn's disease: correlation with intestinal symptoms and hypercatabolism of complement. Gut 1985; 26: 151
   PubMed Web of Science ®Google Scholar
• Jacob H. S. The role of activated complement and granulocytes in shock states and myocardial infarction. J. Lab. Clin. Med. 1981; 98: 645
   Google Scholar
• Wyatt R. J., Bridges R. B., Halatek D. G. Complement levels in cigarette smokers: elevation of serum concentrations of C5, C9 and Cl-inhibitor. J. Clin. Lab. Immunol. 1981; 6: 131
   PubMedGoogle Scholar
• Bridges R. B., Rehm S. R., Wyatt R. J. Increased plasma concentrations of C9, Cl-inhibitor and o,-protease inhibitor associated with cigarette smoking. Life Sci. 1985; 36: 955
   Google Scholar
• Perricone R., de Carolis C, de Sanctis G., Fontana L. Complement activation by cigarette smoke condensate and tobacco infusion. Arch. Environ. Health 1983; 38: 176
   PubMed Web of Science ®Google Scholar
• Wyatt R. J., Farrell M., Berry P. L., Forristal J., Maloney M. J., West C. D. Reduced alternative complement pathway control protein levels in anorexia nervosa: response to parenteral alimentation. Am. J. Clin. Nutr. 1982; 35: 973
   Google Scholar
• Keusch G. T., Torun B., Johnston R. B., Jr., Urrutia J. J. Impairment of hemolytic complement activation by both classical and alternative pathways in serum from patients with kwashiorkor. J. Pediatr. 1984; 105: 434
   Google Scholar
• Gelfand J. A., Donelan M., Burke J. F. Preferential activation and depletion of the alternative complement pathway by burn injury. Ann. Surg. 1983; 198: 58
   Google Scholar
• Vercellotti G. M., Hammerschmidt D. E. Immunological biocompatibility in blood substitutes. Int. Anesthesiol. Clin. 1985; 23: 47
   PubMedGoogle Scholar
• Stuart M. J., Gerrard J. M., White J. G. Effect of cholesterol on production of thromboxane B, by platelets in vitro. N. Engl. J. Med. 1980; 302: 6
   PubMed Web of Science ®Google Scholar
• Ludwig P. W., Hunninghake D. B., Hoidal J. R. Increased leucocyte oxidative metabolism in hyperlipoproteinaemia. Lancet 1982; 2: 348
   PubMed Web of Science ®Google Scholar
• Ivanovich P., Chenoweth D. E., Schmidt R., Klinkmann H., Boxer L. A., Jacob H. S., Hammerschmidt D. E. Symptoms and activation of granuloyctes and complement with two dialysis membranes. Kidney Int. 1983; 24: 758
   PubMed Web of Science ®Google Scholar
• Chenoweth D. E. Complement activation during hemodialysis: clinical observations, proposed mechanisms, and theoretical implications. Artif. Organs 1984; 8: 281
   PubMedGoogle Scholar
• Chenoweth D. E., Cheung A. K., Henderson L. W. Anaphylatoxin formation during hemodialysis: effects of different dialyzer membranes. Kidney Int. 1983; 24: 764
   PubMed Web of Science ®Google Scholar
• McCormick J. R., Kreutzer D. L., Keating H. J., Hupp J., Despins A., Moore M. Alterations in activities of anaphylatoxin inactivator and chemotactic factor inactivator during hemodialysis. Am. J. Pathol. 1982; 109: 283
   Google Scholar
• Hakim R. M., Breillatt J., Lazarus J. M., Port F. K. Complement activation and hypersensitivity rections to dialysis membranes. N. Engl. J. Med. 1984; 311: 878
   PubMed Web of Science ®Google Scholar
• Miller F. N., Hammerschmidt D. E., Anderson G. L., Moore J. N. Protein loss induced by complement activation during peritoneal dialysis. Kidney Int. 1984; 25: 480
   Google Scholar
• Chenoweth D. E., Cooper S. W., Hugli T. E., Stewart R. W., Blackstone E. H., Kirklin J. W. Complement activation during cardiopulmonary bypass. Evidence for generation of C3a and C5a anaphylatoxins. N. Engl. J. Med. 1981; 304: 497
   PubMed Web of Science ®Google Scholar
• Kirklin J. K., Westaby S., Blackstone E. H., Kirklin J. W., Chenoweth D. E., Pacifico A. D. Complement and the damaging effects of cardiopulmonary bypass. J. Thome. Cardiovasc. Surg. 1983; 86: 845
   PubMed Web of Science ®Google Scholar
• Boscoe M. J., Yewdall V. M. A., Thompson M. A., Cameron J. S. Complement activation during cardiopulmonary bypass: quantitative study of effects of methylprednisolone and pulsatile flow. Br. Med. J. 1983; 287: 1747
   Google Scholar
• Rent R., Ertel N., Eisenstein R., Gewurz H. Complement activation by interaction of poly-anions and polycations. I. Heparin-protamine induced consumption of complement. J. Immunol. 1975; 114: 120
   PubMed Web of Science ®Google Scholar
• Best N., Sinosich M. J., Teisner B., Grudzinskas J. G., Fisher M. M. Complement activation during cardiopulmonary bypass by heparin-protamine interaction. Br. J. Anaesth. 1984; 56: 339
   PubMed Web of Science ®Google Scholar
• Arroyave C. M., Bhat N. K., Crown R. Activation of the alternative pathway of the complement system by radiographic contrast media. J. Immunol. 1976; 117: 1866
   PubMed Web of Science ®Google Scholar
• Kolb W. P., Lang J. H., Lasser E. C. Nonimmunologic complement activation in normal human serum induced by radiographic contrast media. J. Immunol. 1978; 121: 1232
   PubMed Web of Science ®Google Scholar
• von Zabern I., Przyklenk H., Nolte R., Vogt W. Effect of metrizamide, a nonionic radiographic contrast agent, on human serum complement. Comparison with ionic contrast media. Int. Arch. Allergy Appl. Immunol. 1984; 73: 321
   Google Scholar
• Fareed J., Moncada R., Messmore H. L., Jr., Walenga J. M., Hoppensteadt D., Wehr-macher W. H. Molecular markers of contrast media-induced adverse reactions. Sem. Thromb. He-most. 1984; 10: 306
   Google Scholar
• Siegle R. L., Lieberman P., Rice M. C. In vitro complement consumption by contrast materials and analogues: reactors vs. nonreactors. Invest. Radiol. 1983; 18: 387
   Google Scholar
• Schneiderman H., Hammerschmidt D. E., McCall A. R., Jacob H. S. Fatal complement-induced leukostasis after diatrizoate injection. Principles of clinicopathologic diagnosis. JAMA 1983; 250: 2340
   Google Scholar
• Tremper K. K., Vercellotti G. M., Hammerschmidt D. E. Hemodynamic profile of adverse clinical reactions to Fluosol-DA 20%. Crit. Care Med. 1984; 12: 428
   PubMedGoogle Scholar
• Vercellotti G. M., Hammerschmidt D. E., Craddock P. R., Jacob H. S. Activation of plasma complement by perfluorocarbon artificial blood: probable mechanism of adverse pulmonary reactions in treated patients and rationale for corticosteroid prophylaxis. Blood 1982; 59: 1299
   PubMed Web of Science ®Google Scholar
• Rosenkvist J., Berkowicz A., Holsoe E., Sorensen H., Taaning E. Plasma exchange in myasthenia gravis complicated with complement activation and urticarial reactions using fresh-frozen plasma as replacement solution. Vox Sang. 1984; 46: 13
   PubMedGoogle Scholar
• Bing D. H. Complement interaction with immune serum globulin and immune globulin intravenous. Am. J. Med. 1984; 76(3A)19
   Google Scholar
• Cunningham-Rundles C. Normalization of serum Clq after intravenous immunoglobulin infusions in hypogammaglobulenemia: dependence upon methods of immunoglobulin preparations. Clin. Immunol. Immunopathol. 1984; 33: 176
   PubMedGoogle Scholar
• Di Perri T., Laghi Pasini F., Ceccatelli L., Pasqui A. L., Capecchi P. L., Orrico A. Captopril-induced granulocyte aggregation. A possible complement mediated mechanism of peripheral leukopenia. J. Immunopharmacol. 1982–1983; 4: 199
   Google Scholar
• von Zabern I., Przyklenk H., Nolte R., Vogt W. Effect of different penicillin derivatives on complement components in human serum. Int. Arch. Allergy Appl. Immunol. 1984; 75: 164
   Google Scholar